Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity

Schizophrenia Research

Volumn 165, Issue 1, 2015, Pages 76-82

  Strassnig, Martin T ^a   Raykov, Tenko ^b   O'Gorman, Cedric ^c   Bowie, Christopher R ^d   Sabbag, Samir ^a   Durand, Dante ^a   Patterson, Thomas L ^e   Pinkham, Amy ^f   Penn, David L ^g,h   Harvey, Philip D ^a,i  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c GENENTECH INC   (United States)

^d QUEEN S UNIVERSITY   (Canada)

^e USCD Medical Center   (United States)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognition; Functional capacity; Negative symptoms; Schizophrenia; Social functioning

Indexed keywords

ADULT; ARTICLE; COGNITION; DAILY LIFE ACTIVITY; DEPRESSION; DISABILITY; FEMALE; FUNCTIONAL STATUS ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MODEL; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SELF REPORT; SOCIAL INTERACTION; VOCATION; AGED; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SOCIAL ADAPTATION;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; COGNITION DISORDERS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT;

EID: 84929501983     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.03.033     Document Type: Article

References (43)

1. Andreasen N.C., Flaum M., Arndt S. The comprehensive assessment of symptoms and history (CASH): an instrument for assessing psychopathology and diagnosis. Arch. Gen. Psychiatry 1992, 49:615-623.
2. Beck A.T., Steer R.A., Brown G.K. Beck Depression Inventory 1996, Manual, Psychological Corp, San Antonio, Texas. 2nd ed.
3. Bollen K.A. Structural Equations with Latent Variables 1989, Wiley, New York.
4. Bowie C.R., Leung W.W., Reichenberg A., McClure M.M., Patterson T.L., Heaton R.K., Harvey P.D. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol. Psychiatry 2008, 63(5):505-511.
5. Bowie C.R., McGurk S.M., Mausbach B.T., Patterson T.L., Harvey P.D. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am. J. Psychiatry 2012, 169:710-718.
6. Breier A., Schreiber J.L., Dyer J., Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch. Gen. Psychiatry 1991, 48:239-246.
7. Carone B.J., Harrow M., Westermeyer J.F. Posthospital course and outcome in schizophrenia. Arch. Gen. Psychiatry 1991, 48:247-253.
8. Couture S.M., Granholm E.L., Fish S.C. A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Schizophr. Res. 2011, 125:152-160.
9. Durand D., Strassnig M., Sabbag S., Twamley E.W., Patterson T.L., Harvey P.D. Factors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies. Eur. Neuropsychopharmacol. 2015, 25:185-191.
10. Fett A.K., Viechtbauer W., Dominguez M.D., Penn D.L., van Os J., Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci. Biobehav. Rev. 2011, 35:573-588.
11. First B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP) New York: Biometrics Research 2002, New York State Psychiatric Institute.
12. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
13. Galderisi S., Rossi A., Rocca P., et al. The influence of illness-related variables, personal resources, and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry 2014, 13:275-287.
14. Gould F., Sabbag S., Durand D., Patterson T.L., Harvey P.D. Self-assessment of functional ability in schizophrenia: milestone achievement and its relationship to accuracy of self-evaluation. Psychiatry Res. 2013, 207(1-2):19-24.
15. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 2000, 26(1):119-136.
16. Green M.F., Kern R.S., Heaton R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res. 2004, 72:41-51.
17. Harvey P.D., Bellack A.S. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?. Schizophr. Bull. 2009, 35(2):300-306.
18. Harvey P.D., Koren D., Reichenberg A., Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 2006, 32:250-258.
19. Harvey P.D., Helldin L., Bowie C.R., Heaton R.K., Olsson A.K., Hjärthag F., Norlander T., Patterson T.L. Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. Am. J. Psychiatry 2009, 166:821-827.
20. Harvey P.D., Raykov T., Twamley E.W., Vella L., Heaton R.K., Patterson T.L. Validating the measurement of real-world functional outcome: phase I results of the VALERO study. Am. J. Psychiatry 2011, 168:1195-2001.
21. Harvey P.D., Sabbag S., Prestia D., Durand D., Twamley E.W., Patterson T.L. Functional milestones and clinician ratings of everyday functioning in people with schizophrenia: overlap between milestones and specificity of ratings. J. Psychiatr. Res. 2012, 46(12):1546-1552.
22. Hegarty J.D., Baldessarini R.J., Tohen M., Waternaux C., Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am. J. Psychiatry 1994, 151(10):1409-1416.
23. Hu L., Bentler P.M. Cut-off criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct. Equ. Model. 1999, 6:55.
24. Kay S.R. Positive and Negative Syndromes in Schizophrenia: Assessment and Research 1991, Brunner/Mazel, New York.
25. Keefe R.S.E., Bilder R.M., Harvey P.D., et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006, 31:2033-2046.
26. Leifker F.R., Bowie C.R., Harvey P.D. Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr. Res. 2009, 115(1):82-87.
27. Leung W.W., Bowie C.R., Harvey P.D. Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: a cross-sectional study. J. Int. Neuropsychol. Soc. 2008, 14(3):479-488.
28. Lin C.-H., Huang C.-H., Chang Y.-C., et al. Clinical symptoms, mainly negative symptoms medicate the influence of neurocognition and social cognition on functional outcome in schizophrenia. Schizophr. Res. 2013, 146:231-237.
29. Little R.J.A., Rubin D.B. Statistical Analysis with Missing Data 2002, Wiley & Sons, New York.
30. Meyer E.C., Carrion R.E., Cornblatt B.A., et al. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr. Bull. 2013, 40(6):1452-1461.
31. Millsap R.E. Statistical Analysis of Measurement Invariance 2012, Taylor & Francis, New York.
32. Patterson T.L., Goldman S., McKibbin C.L., Hughs T., Jeste D.V. UCSD performance-based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr. Bull. 2001, 27:235-245.
33. Pinkham A.E., Penn D.L., Green M.F., Buck B., Healey K., Harvey P.D. The social cognition psychometric evaluation study: results of the expert survey and RAND panel. Schizophr. Bull. 2014, 40(4):813-823.
34. Raykov T., Marcoulides G.A. An Introduction to Applied Multivariate Analysis 2008, Taylor & Francis, New York, London.
35. Raykov T., Marcuolides G.A. On multilevel model reliability estimation from the perspective of structural equation modeling. Struct. Equ. Model. 2006, 13:130-141.
36. Robertson B.R., Prestia D., Twamley E.W., Patterson T.L., Bowie R.C., Harvey P.D. Social competence versus negative symptoms as predictors of real world social functioning in schizophrenia. Schizophr. Res. 2014, 160:136-141.
37. Rosenheck R., Leslie D., Keefe R., McEvoy J., Swartz M., Perkins D., Stroup S., Hsiao J.K., Lieberman J., CATIE Study Investigators Group Barriers to employment for people with schizophrenia. Am. J. Psychiatry 2006, 163(3):411-417.
38. Schneider L.C., Struening E.L. SLOF: a behavioral rating scale for assessing the mentally ill. Soc. Work Res. Abstr. 1983, 19:9-21.
39. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33.
40. Ventura J., Hellemann G.S., Thames A.D. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia. A meta-analysis. Schizophr. Res. 2009, 113(2-3):189-199.
41. Ventura J., Subotnik K.L., Gitlin M.J., et al. Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8years later. Schizophr. Res. 2015, 161:407-411.
42. Wilkinson G.S. Wide-Range Achievement Test 3: Administration Manual 1993, Wide Range, Wilmington, Del.
43. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168(5):472-485.